Skip to main content

Grimes Scott D.'s Form 4 filing

Cardlytics, Inc. (CDLX) · filed Dec 20, 2021

Accession no.
0001666071-21-000247
Filed
Dec 20, 2021
Trade date
Dec 31, 2020-Dec 20, 2021
Filing delay
354 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 9 non-derivative transactions. Open-market sales total $505.2K. It was filed 354 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Grimes Scott D.CIK 0001617486Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 31, 2020Common StockWInheritanceAcquired+55,832$0.00$055,832Indirect
Dec 16, 2021Common StockSSaleDisposed−640$63.03F3−$40,339.254,472Indirect
Dec 16, 2021Common StockSSaleDisposed−640$63.88F5−$40,883.253,832Indirect
Dec 16, 2021Common StockSSaleDisposed−320$65.12F6−$20,838.453,512Indirect
Dec 16, 2021Common StockSSaleDisposed−400$66.00F7−$26,40053,112Indirect
Dec 20, 2021Common StockSSaleDisposed−2,002$61.96F9−$124,043.92254,026Direct
Dec 20, 2021Common StockSSaleDisposed−2,498$62.73F10−$156,699.54251,528Direct
Dec 20, 2021Common StockSSaleDisposed−1,300$63.88F11−$83,044250,228Direct
Dec 20, 2021Common StockSSaleDisposed−200$64.66F12−$12,932250,028Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $62.45 to $63.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (5), (6), (7), (9), (10), (11) and (12) to this Form 4.

Referenced by the price of 1 transaction in Table I.

F5

The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $63.45 to $64.43, inclusive.

Referenced by the price of 1 transaction in Table I.

F6

The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $64.56 to $65.55, inclusive.

Referenced by the price of 1 transaction in Table I.

F7

The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $65.62 to $66.60, inclusive.

Referenced by the price of 1 transaction in Table I.

F9

The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $61.34 to $62.30, inclusive.

Referenced by the price of 1 transaction in Table I.

F10

The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $62.34 to $63.27, inclusive.

Referenced by the price of 1 transaction in Table I.

F11

The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $63.60 to $64.50, inclusive.

Referenced by the price of 1 transaction in Table I.

F12

The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $64.61 to $64.70, inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)